Scleroderma severity and mortality are intrinsically related with the extent of internal tissue damage, systemic sclerosis-related pulmonary fibrosis being one of the leading causes of death in these patients.
This video from Demystifying Medicine – McMaster University attempts to answer a number of questions that you, as a scleroderma patient diagnosed with pulmonary fibrosis and idiopathic pulmonary fibrosis (IPF), might have.
Learn more about Scleroderma here: http://bit.ly/learnscleroderma
Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.